Services
Automation

Design and implement GxP-compliant automation architectures that improve reliability, data integrity, and throughput across pharmaceutical and biotech facilities.
Validation

Develop risk-based validation strategies, protocols, and reports aligned with FDA, EMA, and ICH guidance for new and legacy systems.
TechTransfer

Plan and execute tech transfer for biologics and small molecules, ensuring reproducible performance from development labs to commercial manufacturing.
Automation

PLC, SCADA, DeltaV, Siemens, Rockwell, and multi-vendor automation systems for GMP pharmaceutical and biotech manufacturing environments.
Manufacturing Support

Ensure reliable and efficient manufacturing operations through technical support, troubleshooting, and process optimization across GMP production environments.
Continuous Improvement

Drive operational excellence by identifying process improvement opportunities, reducing waste, increasing equipment efficiency (OEE), optimizing workflows, implementing Lean Six Sigma methodologies, and delivering sustainable performance improvements across manufacturing operations.
About
Engineering confidence into GMP operations
Novalion Engineering Group partners with pharmaceutical and biotech manufacturers to solve complex process, automation, and CQV challenges, combining deep technical expertise with practical project delivery experience across clinical, commercial, and highly regulated environments.

Testimonials
SUSSY Q
.Novalion quickly understood our aseptic filling constraints and delivered an automation upgrade that passed regulatory scrutiny without disrupting commercial supply.
JERRY M.
Their CQV team integrated seamlessly with our internal engineers, helping us achieve on-time qualification for a complex biologics facility expansion.
HOPE P.
From URS development through performance qualification, Novalion provided clear documentation and proactive communication that satisfied both QA and global regulatory expectations.
ADAM S.
Novalion’s structured tech transfer approach reduced variability between our development and manufacturing sites and accelerated readiness for PPQ batches.
Our Experts
biLL mURY
RYAN WALSH
eDUARDO ALVAREZ
Insights
-
June 30, 2026
How Technology Transfer Reduces Manufacturing RiskX
Summary
Discover how a structured technology transfer strategy improves manufacturing readiness, minimizes process variability, reduces operational risk, and supports successful commercialization in pharmaceutical and biotechnology manufacturing.
Contact Novalion
Share your process, automation, or validation challenge and our engineering team will respond with next steps, typical timelines, and how we can support your GMP objectives.
123 River Road, East Stroudsburg, PA phone: 5706565008